1. Home
  2. UG vs CELU Comparison

UG vs CELU Comparison

Compare UG & CELU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo United-Guardian Inc.

UG

United-Guardian Inc.

N/A

Current Price

$6.25

Market Cap

30.2M

ML Signal

N/A

Logo Celularity Inc.

CELU

Celularity Inc.

N/A

Current Price

$1.23

Market Cap

36.0M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
UG
CELU
Founded
1942
2016
Country
United States
United States
Employees
N/A
123
Industry
Package Goods/Cosmetics
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
30.2M
36.0M
IPO Year
1995
N/A

Fundamental Metrics

Financial Performance
Metric
UG
CELU
Price
$6.25
$1.23
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$6.00
AVG Volume (30 Days)
2.8K
101.9K
Earning Date
05-07-2026
05-07-2026
Dividend Yield
7.99%
N/A
EPS Growth
N/A
N/A
EPS
0.20
N/A
Revenue
$12,181,971.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$76.00
P/E Ratio
$32.40
N/A
Revenue Growth
11.91
N/A
52 Week Low
$5.58
$1.01
52 Week High
$9.88
$4.35

Technical Indicators

Market Signals
Indicator
UG
CELU
Relative Strength Index (RSI) 40.87 46.37
Support Level $5.58 $1.21
Resistance Level $6.78 $1.38
Average True Range (ATR) 0.13 0.10
MACD -0.03 -0.00
Stochastic Oscillator 21.92 19.23

Price Performance

Historical Comparison
UG
CELU

About UG United-Guardian Inc.

United-Guardian Inc manufactures and markets cosmetic ingredients, pharmaceuticals, medical lubricants, and specialty industrial products. Its product portfolio includes Klensoft, Deselex, Renacidin, Lubrajel Fluid. The company's pharmaceutical products are sold to and distributed by full-line drug wholesalers throughout the United States. Its medical and specialty industrial products are sold directly by the company to the end-users of those products or, in some cases, to contract manufacturers used by some of those end users. It operates in one business segment and its current product lines are separated into four distinct product categories that are cosmetic ingredients, pharmaceuticals, medical lubricants and sexual wellness. It derives key revenue from the sales made in the U.S.

About CELU Celularity Inc.

Celularity Inc is a clinical-stage biotechnology company developing off-the-shelf placental-derived allogeneic cell therapies including genetically modified and unmodified NK cells, engineered T cells including CAR-T cells, and mesenchymal-like adherent stromal cells, targeting indications across cancer, immunologic, infectious, and degenerative diseases. It manages its operations through an evaluation of three distinct business segments which include Cell Therapy, Degenerative Disease, and bio-banking. The company generates the majority of its revenue from the bio-banking segment.

Share on Social Networks: